
Adipogen/Fumagillin (high purity)/BVT-0424-M001/1 mg
商品编号:
BVT-0424-M001
品牌:
Adipogen Inc
市场价:
¥1400.00
美元价:
840.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Product Details | |
---|---|
Synonyms | Amebacilin; Fugilin; Fumidil; Fumadil B; NSC9168; U5762 |
Product Type | Chemical |
Properties | |
Formula | C26H34O7 |
MW | 458.6 |
Merck Index | 14: 4286 |
CAS | 23110-15-8 |
RTECS | HE1750000 |
Source/Host Chemicals | Isolated from Aspergillus fumigatus (Strain WDMH-35). |
Purity Chemicals | ≥98% (NMR) |
Appearance | Off-white solid. |
Solubility | Soluble in DMSO, acetone or chloroform. Slightly soluble in methanol or ethanol. Insoluble in water. |
Identity | Determined by 1H-NMR and MS. |
Declaration | Manufactured by BioViotica. |
InChi Key | NGGMYCMLYOUNGM-IWMBURASSA-N |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light. |
Use/Stability |
Stable for at least 2 years after receipt when stored at -20°C. Store solutions at -20°C in the dark. |
Documents | |
MSDS |
![]() |
Product Specification Sheet | |
Datasheet |
![]() |
- Meroterpenoid antibiotic.
- Anticancer, antimicrobial, antimalarial and amoebicidal compound. Potent, selective and covalent inhibitor of methionine aminopeptidase-2 (MetAP2).
- Anti-angiogenic by impairing the growth of endothelial cells and altering gene expression.
- Inhibits endothelial cell proliferation in vitro and tumor-induced angiogenesis in vivo.
- Suppresses the HIV-1 infection of human macrophages through the inhibition of HIV-1 viral protein R (Vpr) activity.
- Inhibits neovascularization and might be useful in non-tumor diseases such as diabetic retinopathy, arthritis and psoriasis, which involve neovascularisation processes.
- Reduces diet-induced adipose tissue formation in mice, independent of its effects on angiogenesis.
Product References
- Antibiotic substance produced by Aspergillus fumigatus: T.E. Eble, et al.; Antibiot. Chemother. 1, 54 (1951)
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth: D. Ingber, et al.; Nature 348, 555 (1990)
- The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2: N. Sin, et al.; PNAS 94, 6099 (1997)
- Inhibition of Angiogenesis In Vivo by ets-1 Antisense Oligonucleotides-Inhibition of Ets-1 Transcription Factor Expression by the Antibiotic Fumagillin: N. Wernert, et al.; Angew. Chem. Int. Ed. Engl. 38, 3228 (1999)
- Structure elucidation of fumagillin-related natural products: J. Halasz, et al.; Tetrahedron 56, 10081 (2000)
- A re-evaluation of fumagillin selectivity towards endothelial cells: S. Rodriguez-Nieto, et al.; Anticancer Res. 21, 3457 (2001)
- Fumagillin treatment of intestinal microsporidiosis: J. Molina, et al.; N. Engl. J. Med. 346, 1963 (2002)
- Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells: C.M. Mazzanti, et al.; Genome Res. 14, 1585 (2004)
- Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity: N. Watanabe, et al.; FEBS Lett. 580, 2598 (2006)
- Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors: B. Lefkove, et al.; Expert Rev. Anti-Infect. Ther. 5, 573 (2007)
- Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo: X. Chen, et al.; Chem. Biol. 16, 193 (2009)
- Fumagillin inhibits colorectal cancer growth and metastasis in mice: in vivo and in vitro study of anti-angiogenesis: L. Hou, et al.; Pathol. Int. 59, 448 (2009)
- Syntheses of fumagillin and ovalicin: J. Yamaguchi & Y. Hayashi; Chem. Eur. J. 16, 3884 (2010)
- Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity: H.R. Lijnen, et al.; Obesity 18, 2241 (2010)
- Inhibition of neutrophil function following exposure to the Aspergillus fumigatus toxin fumagillin: J.P. Fallon, et al.; J. Med. Microbiol. 59, 625 (2010)
- Fumagillin and structurally related molecules as source of new drugs: D. Gamba-Sanches; Mini-Rev. Org. Chem. 9, 126 (2012)
- Stimulation of suicidal erythrocyte death by fumagillin: M. Zbidah, et al.; Basic Clin. Pharmacol. Toxicol. 112, 346 (2013)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们